Thanks to the RAND Corporation, Delphi emerged as a necessity of gathering expert input in a systematic way by the means of questionnaire with controlled opinion feedback.
Professor Carlos Bana e Costa, of the Technical University of Lisbon creates the MCDA method which would ground our softwares some decades later.
This is where it all begun for us! We developed the first platform for the elicitation of patient’s preferences in an investigation project with the European Medicines Agency.
Imagine this, in the same year that we are starting to apply MCDA to HTA, we also developed the first platform to implement the Delphi method under the umbrella of the Euro-Healthy project: "Shaping EUROpean policies to promote HEALTH equitY"
The first commercial version of the Welphi project reaches the market. Several companies start using it for the selection of indicators, criteria or policies, right away
An innovative new methodology for evaluating the benefits of new medicines has been developed by a team of researchers led by health economics and policy experts from the Department of Health Policy at LSE.
The first release of WISEDON meets the spotlight! Multiple criteria decision analysis can now be used throughout simple workflow to provide powerful new insights to HTA
It takes a fantastic team to spread the word. Decision eyes was created to develop new and improved tools for a faster and more inclusive HTA.
In the beginning of 2019, Decision Eyes raised its first pre-seed round of investment.
Decision eyes received funding from PT 2020 to promote the company's internationalization.
(project page)
Co-founder and CEO
Co-founder and chief scientific officer
Co-founder and chief scientific officer
Software Engineer
Chief Operating Officer
Software Engineer - Trainee